The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics

M. Solèr, J. Matz, R. Townley, R. Buhl, J. O'Brien, H. Fox, J. Thirlwell, N. Gupta, G. Della Cioppa

Research output: Contribution to journalArticlepeer-review

714 Scopus citations

Fingerprint Dive into the research topics of 'The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics'. Together they form a unique fingerprint.

Medicine & Life Sciences